BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

346 related articles for article (PubMed ID: 28109089)

  • 21. Targeting of cell cycle and let-7a/STAT3 pathway by niclosamide inhibits proliferation, migration and invasion in oral squamous cell carcinoma cells.
    Li X; Ding R; Han Z; Ma Z; Wang Y
    Biomed Pharmacother; 2017 Dec; 96():434-442. PubMed ID: 29031202
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Licochalcone B induces apoptosis of human oral squamous cell carcinoma through the extrinsic- and intrinsic-signaling pathways.
    Oh H; Yoon G; Shin JC; Park SM; Cho SS; Cho JH; Lee MH; Liu K; Cho YS; Chae JI; Shim JH
    Int J Oncol; 2016 Apr; 48(4):1749-57. PubMed ID: 26847145
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Antitumor effect of betulinic acid on human acute leukemia K562 cells in vitro.
    Wu Q; He J; Fang J; Hong M
    J Huazhong Univ Sci Technolog Med Sci; 2010 Aug; 30(4):453-7. PubMed ID: 20714869
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Inhibition of esophageal-carcinoma cell proliferation by genistein via suppression of JAK1/2-STAT3 and AKT/MDM2/p53 signaling pathways.
    Gao J; Xia R; Chen J; Gao J; Luo X; Ke C; Ren C; Li J; Mi Y
    Aging (Albany NY); 2020 Apr; 12(7):6240-6259. PubMed ID: 32276266
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Genistein nanoformulation promotes selective apoptosis in oral squamous cell carcinoma through repression of 3PK-EZH2 signalling pathway.
    Dev A; Sardoiwala MN; Kushwaha AC; Karmakar S; Choudhury SR
    Phytomedicine; 2021 Jan; 80():153386. PubMed ID: 33113500
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Betulinic acid decreases ER-negative breast cancer cell growth in vitro and in vivo: role of Sp transcription factors and microRNA-27a:ZBTB10.
    Mertens-Talcott SU; Noratto GD; Li X; Angel-Morales G; Bertoldi MC; Safe S
    Mol Carcinog; 2013 Aug; 52(8):591-602. PubMed ID: 22407812
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Quinalizarin exerts an anti-tumour effect on lung cancer A549 cells by modulating the Akt, MAPK, STAT3 and p53 signalling pathways.
    Meng LQ; Liu C; Luo YH; Piao XJ; Wang Y; Zhang Y; Wang JR; Wang H; Xu WT; Liu Y; Wu YQ; Sun HN; Han YH; Jin MH; Shen GN; Zang YQ; Li J; Fang NZ; Cui YD; Jin CH
    Mol Med Rep; 2018 Feb; 17(2):2626-2634. PubMed ID: 29207064
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Betulinic acid decreases specificity protein 1 (Sp1) level via increasing the sumoylation of sp1 to inhibit lung cancer growth.
    Hsu TI; Wang MC; Chen SY; Huang ST; Yeh YM; Su WC; Chang WC; Hung JJ
    Mol Pharmacol; 2012 Dec; 82(6):1115-28. PubMed ID: 22956772
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Betulinic Acid Induces ROS-Dependent Apoptosis and S-Phase Arrest by Inhibiting the NF-
    Shen M; Hu Y; Yang Y; Wang L; Yang X; Wang B; Huang M
    Oxid Med Cell Longev; 2019; 2019():5083158. PubMed ID: 31281581
    [TBL] [Abstract][Full Text] [Related]  

  • 30. p53-targeted lincRNA-p21 acts as a tumor suppressor by inhibiting JAK2/STAT3 signaling pathways in head and neck squamous cell carcinoma.
    Jin S; Yang X; Li J; Yang W; Ma H; Zhang Z
    Mol Cancer; 2019 Mar; 18(1):38. PubMed ID: 30857539
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Buddlejasaponin IV induces cell cycle arrest at G2/M phase and apoptosis in immortalized human oral keratinocytes.
    Hwang YS; Chung WY; Kim J; Park HJ; Kim EC; Park KK
    Phytother Res; 2011 Oct; 25(10):1503-10. PubMed ID: 21394802
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Dioscin-6'-O-acetate inhibits lung cancer cell proliferation via inducing cell cycle arrest and caspase-dependent apoptosis.
    Li X; Qu Z; Jing S; Li X; Zhao C; Man S; Wang Y; Gao W
    Phytomedicine; 2019 Feb; 53():124-133. PubMed ID: 30668391
    [TBL] [Abstract][Full Text] [Related]  

  • 33. In vivo protective effect of betulinic acid on dexamethasone induced thymocyte apoptosis by reducing oxidative stress.
    Yi J; Zhu R; Wu J; Wu J; Xia W; Zhu L; Jiang W; Xiang S; Tan Z
    Pharmacol Rep; 2016 Feb; 68(1):95-100. PubMed ID: 26721359
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Betulinic acid inhibits autophagic flux and induces apoptosis in human multiple myeloma cells in vitro.
    Yang LJ; Chen Y; He J; Yi S; Wen L; Zhao J; Zhang BP; Cui GH
    Acta Pharmacol Sin; 2012 Dec; 33(12):1542-8. PubMed ID: 23064721
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Oridonin induces G2/M cell cycle arrest and apoptosis in human oral squamous cell carcinoma.
    Wang H; Zhu L; Feng X; Zhang H; Luo Q; Chen F
    Eur J Pharmacol; 2017 Nov; 815():282-289. PubMed ID: 28935563
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Betulinic acid inhibits stemness and EMT of pancreatic cancer cells via activation of AMPK signaling.
    Sun L; Cao J; Chen K; Cheng L; Zhou C; Yan B; Qian W; Li J; Duan W; Ma J; Qi D; Wu E; Wang Z; Liu Q; Ma Q; Xu Q
    Int J Oncol; 2019 Jan; 54(1):98-110. PubMed ID: 30365057
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Betulinic acid chemosensitizes breast cancer by triggering ER stress-mediated apoptosis by directly targeting GRP78.
    Cai Y; Zheng Y; Gu J; Wang S; Wang N; Yang B; Zhang F; Wang D; Fu W; Wang Z
    Cell Death Dis; 2018 May; 9(6):636. PubMed ID: 29802332
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Betulinic acid suppresses STAT3 activation pathway through induction of protein tyrosine phosphatase SHP-1 in human multiple myeloma cells.
    Pandey MK; Sung B; Aggarwal BB
    Int J Cancer; 2010 Jul; 127(2):282-92. PubMed ID: 19937797
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Inhibition of phosphotidylinositol-3 kinase pathway by a novel naphthol derivative of betulinic acid induces cell cycle arrest and apoptosis in cancer cells of different origin.
    Majeed R; Hamid A; Sangwan PL; Chinthakindi PK; Koul S; Rayees S; Singh G; Mondhe DM; Mintoo MJ; Singh SK; Rath SK; Saxena AK
    Cell Death Dis; 2014 Oct; 5(10):e1459. PubMed ID: 25299784
    [TBL] [Abstract][Full Text] [Related]  

  • 40. In vitro and in vivo anti-tumor effect of metformin as a novel therapeutic agent in human oral squamous cell carcinoma.
    Luo Q; Hu D; Hu S; Yan M; Sun Z; Chen F
    BMC Cancer; 2012 Nov; 12():517. PubMed ID: 23151022
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 18.